Fast-track HCV check-up enhances possibility of sustained virologicalresponse in HCV infected patientsJOURNAL OF HEPATOLOGYIF332018-04-010PREAI
Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation: Results From the ANRS CO23 CUPILT StudyTRANSPLANTATIONIF52018-01-0113PREAI
Feasibility of anti-HCV direct acting anti-viral agents in French prison settingsJOURNAL OF HEPATOLOGYIF332017-01-010PREAI
Treatment and prognosis of acute severe autoimmune hepatitisJOURNAL OF HEPATOLOGYIF332017-01-016PREAI
SHOULD WE KEEP USING RIBAVIRIN TO TREAT HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION? RESULTS FROM THE CO23 ANRS CUPILT STUDYJOURNAL OF HEPATOLOGYIF332016-01-012PREAI
EFFECT OF SOFOSBUVIR/DACLATASVIR± RIBAVIRIN ON THE PHARMACOKINETICS OF CALCINEURIN INHIBITORS IN LIVER TRANSPLANT RECIPIENTS - FROM THE ANRS CO23 CUPILT STUDYJOURNAL OF HEPATOLOGYIF332016-01-010PREAI
LONG-TERM OUTCOME IN LIVER TRANSPLANTATION CANDIDATES WITH PORTOPULMONARY HYPERTENSIONJOURNAL OF HEPATOLOGYIF332016-01-010PREAI
RENAL DYSFUNCTION IN LIVER TRANSPLANT PATIENTS TREATED WITH SOFOSBUVIR BASED-REGIMEN FOR HCV RECURRENCE: RESULTS FROM A LARGE FRENCH PROSPECTIVE MULTICENTRIC ANRS CO23 CUPILTJOURNAL OF HEPATOLOGYIF332016-01-012PREAI
EFFICACY OF SOFOSBUVIR AND DACLATASVIR IN HIV/HCV CO-INFECTED PATIENTS WITH ADVANCED FIBROSISJOURNAL OF HEPATOLOGYIF332015-04-014PREAI
THE ASSOCIATION OF SOFOSBUVIR AND DACLATASVIR FOR TREATING SEVERE RECURRENCE OF HCV INFECTION AFTER LIVER TRANSPLANTATION: RESULTS FROM A LARGE FRENCH PROSPECTIVE MULTICENTRIC ANRS CO23 CUPILT COHORTJOURNAL OF HEPATOLOGYIF332015-04-0116PREAI
MELD SCORE KINETICS AND SURVIVAL IN HIV/HCV PATIENTS: THE ANRS EP 25 PRETHEVIC COHORTJOURNAL OF HEPATOLOGYIF332015-04-010PREAI
TREATMENT OF SEVERE HCV-RECURRENCE AFTER LIVER TRANSPLANTATION USING SOFOSBUVIR-BASED REGIMENS: THE ANRS CO23 CUPILT STUDYJOURNAL OF HEPATOLOGYIF332015-04-010PREAI
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation在HIV/丙型肝炎病毒合并感染的患者中使用boceprevir或telaprevir治疗肝移植后丙型肝炎病毒感染的复发AIDSIF3.12015-01-0225OAAI
IMPACT OF ANEMIA IN VIRAL RESPONSE DURING TRIPLE THERAPY IN LIVER TRANSPLANT RECIPIENTSJOURNAL OF HEPATOLOGYIF332014-04-010PREAI
AUTOANTIBODY SIGNATURES AS BIOMARKER FOR CHOLANGIOCARCINOMA DEFINED BY SEROLOGICAL PROTEOME ANALYSISJOURNAL OF HEPATOLOGYIF332014-04-010PREAI
HEPATITIS E INFECTION IN PATIENTS WITH SEVERE ACUTE ALCOHOLIC HEPATITISJOURNAL OF HEPATOLOGYIF332014-04-010PREAI
ANTI-HEPATITIS C (HCV) TRIPLE THERAPY WITH PROTEASE INHIBITORS IN HIV/HCV CO-INFECTED PATIENTS AFTER LIVER TRANSPLANTATIONJOURNAL OF HEPATOLOGYIF332014-04-010PRE
PREDICTIVE FACTORS OF SURVIVAL AND PROGNOSTIC SCORE VALIDATION IN LIVER RETRANSPLANTATION FOR SEVERE HEPATITIS C RECURRENCE: THE IMPORTANCE OF HCV THERAPY BEFORE AND AFTER RETRANSPLANTATIONJOURNAL OF HEPATOLOGYIF332013-04-010OAAI
END OF TREATMENT RESPONSE AFTER PROTEASE INHIBITOR (PI)-BASED THERAPY FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC EUROPEAN EXPERIENCEJOURNAL OF HEPATOLOGYIF332013-04-016PREAI
IMPACT OF SARCOPENIA ON MORTALITY AFTER LIVER TRANSPLANTATION IN HIV INFECTED PATIENTSJOURNAL OF HEPATOLOGYIF332013-04-010OAAI